Lev Becker1, Leila Kheirandish-Gozal1, Eduard Peris1, Kelly Q Schoenfelt1, David Gozal2. 1. Section of Pediatric Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA. 2. Section of Pediatric Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA. Electronic address: dgozal@uchicago.edu.
Abstract
BACKGROUND: Intrinsic variance of the urine proteome limits the discriminative power of proteomic analysis and complicates potential biomarker detection in the context of paediatric sleep disorders. METHODS AND RESULTS: Using a rigorous workflow for proteomic analysis of urine, we demonstrate that gender and diurnal effects constitute two important sources of variability in healthy children. In the context of disease, complex pathophysiological perturbations magnify these proteomic differences and therefore require contextualised biomarker analysis. Indeed, by performing biomarker discovery in a gender- and diurnal-dependent manner, we identified ∼30-fold more candidate biomarkers of paediatric obstructive sleep apnoea (OSA), a highly prevalent condition in children characterised by repetitive episodes of intermittent hypoxia and hypercapnia, and sleep fragmentation in the context of recurrent upper airway obstructive events during sleep. Remarkably, biomarkers were highly specific for gender and sampling time as poor overlap (∼3%) was observed in the proteins identified in boys and girls across morning and bedtime samples. CONCLUSIONS: As no clinical basis to explain gender-specific effects in OSA or healthy children is apparent, we propose that implementation of contextualised biomarker strategies will be applicable to a broad range of human diseases, and may be specifically applicable to paediatric OSA.
BACKGROUND: Intrinsic variance of the urine proteome limits the discriminative power of proteomic analysis and complicates potential biomarker detection in the context of paediatric sleep disorders. METHODS AND RESULTS: Using a rigorous workflow for proteomic analysis of urine, we demonstrate that gender and diurnal effects constitute two important sources of variability in healthy children. In the context of disease, complex pathophysiological perturbations magnify these proteomic differences and therefore require contextualised biomarker analysis. Indeed, by performing biomarker discovery in a gender- and diurnal-dependent manner, we identified ∼30-fold more candidate biomarkers of paediatric obstructive sleep apnoea (OSA), a highly prevalent condition in children characterised by repetitive episodes of intermittent hypoxia and hypercapnia, and sleep fragmentation in the context of recurrent upper airway obstructive events during sleep. Remarkably, biomarkers were highly specific for gender and sampling time as poor overlap (∼3%) was observed in the proteins identified in boys and girls across morning and bedtime samples. CONCLUSIONS: As no clinical basis to explain gender-specific effects in OSA or healthy children is apparent, we propose that implementation of contextualised biomarker strategies will be applicable to a broad range of human diseases, and may be specifically applicable to paediatric OSA.
Authors: Carolyn M Slupsky; Kathryn N Rankin; James Wagner; Hao Fu; David Chang; Aalim M Weljie; Erik J Saude; Bruce Lix; Darryl J Adamko; Sirish Shah; Russ Greiner; Brian D Sykes; Thomas J Marrie Journal: Anal Chem Date: 2007-08-17 Impact factor: 6.986
Authors: Ruth Hüttenhain; Martin Soste; Nathalie Selevsek; Hannes Röst; Atul Sethi; Christine Carapito; Terry Farrah; Eric W Deutsch; Ulrike Kusebauch; Robert L Moritz; Emma Niméus-Malmström; Oliver Rinner; Ruedi Aebersold Journal: Sci Transl Med Date: 2012-07-11 Impact factor: 17.956
Authors: Lukas U Zimmerli; Eric Schiffer; Petra Zürbig; David M Good; Markus Kellmann; Laetitia Mouls; Andrew R Pitt; Joshua J Coon; Roland E Schmieder; Karlheinz H Peter; Harald Mischak; Walter Kolch; Christian Delles; Anna F Dominiczak Journal: Mol Cell Proteomics Date: 2007-10-19 Impact factor: 5.911
Authors: Esther Oceja; Paula Rodríguez; María José Jurado; Maria Luz Alonso; Genoveva Del Río; María Ángeles Villar; Olga Mediano; Marian Martínez; Santiago Juarros; Milagros Merino; Jaime Corral; Carmen Luna; Leila Kheirandish-Gozal; David Gozal; Joaquín Durán-Cantolla Journal: Methods Protoc Date: 2021-01-19
Authors: Brittany A Leader; Bala S C Koritala; Charles A Moore; Elaine H Grigg Dean; Leah C Kottyan; David F Smith Journal: J Clin Sleep Med Date: 2021-12-01 Impact factor: 4.062